1. Introduction {#sec1}
===============

Postoperative endophthalmitis is a potentially sight-threatening infection which represents a therapeutic emergency \[[@B1], [@B2]\]. The mechanism of postoperative endophthalmitis has not been entirely elucidated to date. However, the binding of bacteria to intraocular lenses (IOLs) and biofilm formation are well known to be an essential step in the pathogenesis of endophthalmitis \[[@B3], [@B4]\]. Study of the biofilm formation appears to be essential for gaining a better understanding of the relationship between endophthalmitis \[[@B5]\] and the materials of the IOL \[[@B6]--[@B8]\]and developing new therapeutic or prevention strategies against endophthalmitis \[[@B9], [@B10]\].

Ten patients were consecutively found to have membrane formation on the same type of IOLs after uneventful IOL implantation in our hospital within one year. However, no other patients were found with a similar phenomenon using other types of IOLs during this time. This series of cases attracted our attention, and we wondered whether the biomaterial of this IOL may be more susceptible to bacterial adherence. There have been several previous studies focused on the bacterial adhesion to IOLs and biofilm formation and demonstrated that bacterial adhesion and biofilm development on the IOL surface depended on the characteristics of the biomaterial \[[@B5]--[@B8], [@B10], [@B11]\]. However, there were some discrepancies among these studies.

Here, we reported this case series of patients with membrane formation on the IOLs and evaluated their treatments and outcomes. The aim of this study was to develop an *in vitro* model to study *Staphylococcus epidermidis* biofilm formation and to compare the ability of *S. epidermidis* to form biofilms on various IOL materials as a step towards deepening the understanding of the interactions between pathogenic bacteria and IOL materials.

2. Patients and Methods {#sec2}
=======================

2.1. Demographics and Medical Histories {#sec2.1}
---------------------------------------

The Institutional Review Board (IRB) of the Eye and ENT Hospital of Fudan University approved this study, which adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from the subjects. The study included ten eyes of ten patients who were found to have membranes on their IOLs (QUATRIX Aspheric IOLs, Croma GmbH) for the treatment of age-related cataract from May 2015 to May 2016. Their medical records were reviewed ([Table 1](#tab1){ref-type="table"}).

In our study, the detailed numbers of seven different types of IOLs implanted in cataract patients from May 2015 to May 2016 were also reported in [Table 2](#tab2){ref-type="table"}. Patients with uveitis, glaucoma, or diabetic retinopathy (51 eyes) were implanted with the heparin surface-modified (HSM) hydrophilic acrylic IOLs.

2.2. Surgical Technique {#sec2.2}
-----------------------

All surgery was performed by two experienced doctors, using conventional phacoemulsification with IOLs implanted in the capsular bag. The postoperative medications given were levofloxacin and prednisolone acetate, four times/day for 2 weeks, and pranoprofen, four times/day for 4 weeks.

2.3. Intraocular Lenses {#sec2.3}
-----------------------

The study involved seven types of commercially available IOLs made from two different biomaterials: hydrophilic and hydrophobic acrylic ([Table 2](#tab2){ref-type="table"}).

2.4. Bacterial Strain and Medium Composition {#sec2.4}
--------------------------------------------

The Institute of Medical Microbiology of Shanghai Medical College of Fudan University provided the *S. epidermidis* strain 1457 (SE1457) described in the previous study \[[@B12]\]. B-medium and Tryptic soy broth (TSB, Oxoid, Cambridge, UK) were used for *S. epidermidis* cultivation and biofilm formation. The artificial aqueous humour was prepared by adding casein peptone (1.0 g/L), yeast extract (0.5 g/L), and glucose (1.0 g/L) in sterile physiological balanced salt solution.

2.5. Dynamic Biofilm Assay {#sec2.5}
--------------------------

Bacterial biofilms formation *in vitro* was performed using the BioFlux 1000Z microfluidic system (Fluxion Biosciences, Inc., San Francisco, CA, USA). The inlet wells of a BioFlux Plate (48 wells, 20 dyne) were seeded with a 10^8^ CFU/mL SE1457 bacterial solution by pumping from the inlet wells to the outlet wells at 2.0 dyne/cm^2^ for 8 s. The plate was incubated at 37°C for 30 min without flow to let bacteria cells adhere to the surface of the channels between the inlet and outlet wells. After cleaning the outlet wells, the IOLs were placed horizontally at the bottom. A total of 2.0 mL of artificial aqueous humour was added to the inlet wells and pumped at 37°C with a consistent flow (0.15 dyne/cm^2^) towards outlet wells for 36 h.

2.6. Scanning Electron Microscopy (SEM) Observations of IOLs and Biofilms {#sec2.6}
-------------------------------------------------------------------------

IOLs were fixed in 2.5% glutaraldehyde solution in a 0.1 M phosphate buffer for 2 h, followed by a secondary fixation with 1% osmium tetroxide stationary solution. Fixed IOLs were dehydrated in ethanol-water mixtures with increasing concentrations of ethanol and ethyl acetate. The IOL surface observations were performed at 10 kV with an SEM (JEOL JSM-6380LV; JEOL Ltd, Tokyo, Japan, and FEI Nova NanoSEM 450; FEI Ltd, Oregon, USA).

2.7. Quantification of Bacterial Adhesion {#sec2.7}
-----------------------------------------

Gentle scraping of both optic surfaces of IOLs was performed to remove the adhered bacteria cells. Bacterial aggregates were subsequently dissociated through the needle of a syringe and vortexed for 3 min. The resultant suspension was then diluted and spread over a nutritive agar plate (TSB). Colonies were counted as colony-forming units (CFU)/mm^2^ after 24 h of incubation at 37°C.

2.8. Data Analysis {#sec2.8}
------------------

Snellen VAs were converted to the logarithm of the minimum angle of resolution (logMAR) values for data analyses. All statistical analyses were performed using SPSS for Windows (ver. 13.0, SPSS, Inc., Chicago, IL, USA). Mean values with the standard deviation of the mean (±SD) are reported unless otherwise stated. *P* values \<0.05 were considered statistically significant and of \<0.01 highly significant.

3. Results {#sec3}
==========

3.1. Clinical Case Series {#sec3.1}
-------------------------

### 3.1.1. Treatments and Outcomes {#sec3.1.1}

From May 2015 to May 2016, there were 11236 patients who received implantations of IOLs in our hospital. Ten patients were found to have membrane formation on the same type of IOLs ([Table 1](#tab1){ref-type="table"}), and no membrane formation was found on any other types of IOLs ([Table 2](#tab2){ref-type="table"}). The incidence of endophthalmitis with membrane formation on the IOL surface was 0.89%. These patients had a mean age of 66.50 ± 8.63 years, and the median time until membrane development was found to be 27.50 ± 20.90 days.

Among these patients, five of ten eyes received long-term tropical treatment of gatifloxacin/levofloxacin and tobramycin. Three of ten eyes underwent intravitreal injections of norvancomycin 1 mg/0.1 mL and ceftazidime 2.25 mg/0.1 mL, and two of ten eyes underwent pars plana vitrectomy (PPV) plus intravitreal injections of ceftazidime and norvancomycin. All of the patients were treated with long-term (at least one month) tropical treatment of gatifloxacin/levofloxacin and tobramycin. At the last follow-up, all patients had best-corrected visual acuity (BCVA) of 20/50 or better. The ten eyes had a mean preoperative logMAR VA of 0.800 ± 0.267, which decreased after membrane formation (logMAR VA of 1.160 ± 0.350). Their final logMAR BCVA improved to 0.190 ± 0.120 at the last visit after treatment compared with VA before cataract surgery (*P* \< 0.001).

There were three types of patients: acute onset, chronic onset, and recurrent membrane formation. We report the representative cases below.

### 3.1.2. Acute Onset Membrane Formation (Case 7) {#sec3.1.2}

A 67-year-old female complained of visual loss, pain, and a foreign body sensation in the operated eye three days after surgery. On examination, VA of the right eye was 20/200 and found membrane formation around the IOL and capsule with 2+ anterior chamber cell and flare ([Figure 1](#fig1){ref-type="fig"}). Dilated fundus examination showed mild to moderate vitreous opacification. This patient was then treated with a vitreous injection of intravitreal ceftazidime and norvancomycin, as well as topical medication. The anterior chamber and vitreous culture were negative. After one week, her VA improved to 20/50.

### 3.1.3. Chronic Onset Membrane Formation (Case 8) {#sec3.1.3}

A 55-year-old man complained of a two-month history of visual blurriness and photophobia ([Figure 1](#fig1){ref-type="fig"}). The symptoms appeared 3 weeks after the surgery. On examination, visual acuity of the right eye was 20/2000 and IOP was 32.6 mmHg. Dilated fundus examination showed moderate vitreous opacification. This patient was treated with PPV and vitreous injection. Inflammatory exudate from the anterior chamber culture was obtained by needle tap and subsequently grew *S. epidermidis* sensitive to levofloxacin and resistant to clindamycin. Postoperatively, this patient was treated with tropical medication. After one month, his VA improved to 20/100.

### 3.1.4. Recurrent Membrane Formation (Case 6) {#sec3.1.4}

A 58-year-old female complained of visual loss and redness in the operated eye forty days after surgery. On examination, VA of the right eye was 20/200. Slit-lamp examination found membrane formation on the anterior optic part of the IOL with 1 + anterior chamber flare. Dilated fundus examination showed mild vitreous opacification. The patient was diagnosed with noninfectious iritis and anterior capsular opacification. After two weeks of topical application of corticosteroids until the inflammation subsided, this patient received Nd:YAG capsulotomy. However, the membrane on the IOL appeared again two days after capsulotomy with 4 + anterior chamber cell, hypopyon, and anterior chamber fibrin, with an IOP of 40 mmHg. B-scan demonstrated mild to moderate vitreous opacification. The patient then underwent PPV and intravitreal injections, with tropical medication. The patient demonstrated clinical improvement, and two weeks later, her visual acuity improved to 20/40, with an IOP of 14 mmHg.

3.2. Comparative Study of Different IOLs {#sec3.2}
----------------------------------------

In our study, we compared the characteristics of seven types of IOL used in our clinical practice ([Table 2](#tab2){ref-type="table"}), including the material characteristics and the presence of *S. epidermidis* biofilms on the IOL surface by SEM.

### 3.2.1. SEM of IOLs {#sec3.2.1}

The hydrophobic acrylic IOLs showed a smooth surface or rare tiny fragments ([Figure 2](#fig2){ref-type="fig"}). However, the hydrophilic acrylic IOLs reflected varied manifestations. Two types of hydrophilic acrylic IOLs had tiny fragments on their surface (Figures [2(a)](#fig2){ref-type="fig"} and [2(c)](#fig2){ref-type="fig"}). Heparin surface-modified (HSM) hydrophilic acrylic IOLs were found to have dendritic crystals ([Figure 2(b)](#fig2){ref-type="fig"}). There were massive fern-like or shield-like crystals on two types of hydrophilic acrylic IOLs (Figures [2(d)](#fig2){ref-type="fig"}--[2(f)](#fig2){ref-type="fig"}).

### 3.2.2. SEM of Biofilm Development on IOLs {#sec3.2.2}

There were isolated or aggregated cocci on all types of IOL optic surfaces by SEM. As depicted in [Figure 3](#fig3){ref-type="fig"}, SE1457 appeared to adhere more to hydrophilic IOLs than to hydrophobic IOLs, and it was found that the biofilm formation on the hydrophobic IOLs was the lowest among the materials tested (Figures [3(g)](#fig3){ref-type="fig"} and [3(h)](#fig3){ref-type="fig"}). As observed in [Figure 3](#fig3){ref-type="fig"}, there were no significant differences among the three brands of hydrophilic acrylic IOLs at 36 h (Figures [3(c)](#fig3){ref-type="fig"}--[3(f)](#fig3){ref-type="fig"}). However, there were significant differences between brands of hydrophilic IOLs (Figures [3(a)](#fig3){ref-type="fig"}--[3(f)](#fig3){ref-type="fig"}). The biofilms on HSM hydrophilic acrylic IOLs were significantly greater than those on the other materials after 36 h.

### 3.2.3. Bacterial Population Enumeration in IOL Biofilms {#sec3.2.3}

After 36 h of incubation, the number of bound bacteria per unit area increased the most from hydrophobic acrylic to hydrophilic acrylic ([Table 3](#tab3){ref-type="table"}). [Table 3](#tab3){ref-type="table"} shows the differences in bacterial adhesion to the biomaterials (*P* \< 0.001). Quantitative plate counting revealed no significant difference in the attached bacterial numbers of adherent bacteria among the two hydrophobic IOLs. SE1457 appeared to adhere more to the hydrophilic lens than to the hydrophobic IOLs, but the difference was not statistically significant (*P* \< 0.05 in F vs B, F vs E, G vs B, G vs D, and G vs E). As illustrated in [Table 3](#tab3){ref-type="table"}, there were no significant differences in the number of adherent bacteria between the F brand and the G brand of hydrophobic IOLs (*P* \> 0.05). However, significant differences were observed among the hydrophilic IOLs. Specifically, the A-brand hydrophilic acrylic IOLs were distinct from the four other hydrophilic acrylic IOLs (*P* \< 0.05); HSM hydrophilic acrylic IOLs had the most bacteria, but there were no significant differences compared with D-brand and E-brand hydrophilic acrylic IOLs (*P* \> 0.05).

4. Discussion {#sec4}
=============

Postoperative bacterial endophthalmitis is considered to be one of the most feared complications and needs urgent treatment \[[@B13]\]. These ten patients in our study were all treated for endophthalmitis even though only one patient was found to have a positive culture. Our active anti-infection management proved effective and obtained a good visual outcome. Management of postoperative bacterial endophthalmitis has been explored in many studies \[[@B13]\]. Whether to perform lensectomy and posterior capsule stripping as a first-line procedure, along with vitreous tap and intravitreal injections of antibiotics, has been discussed in previous studies \[[@B2], [@B13], [@B14]\]. If the clinical phenomenon is not improving after intravitreal antibiotics within 24 h, or culture of a biofilm-producing organism is positive, vitrectomy should be considered urgently with vitreous cavity antibiotic administration. We recommend that lensectomy and posterior capsule stripping should be performed only in cases where the infection proves to be resistant to antibiotics.

Organism isolation is the fundamental basis of treatment. The initial cultures performed in our study were mostly negative. Prophylactic antibiotics may affect bacterial isolates \[[@B15]\]. Furthermore, previous reports have suggested that some bacteria will only grow on special culture media or under certain conditions \[[@B16]\]. In our case series, all cultures grew on the routine culture medium. The only positive culture found was *S. epidermidis*, which commonly exists on human skin and may be able to cause opportunistic infections.

Staphylococcal biofilm formation is modulated by many variables, including environmental factors such as bacterial strains, type of medium, temperature, hydrodynamic forces, different experimental protocols, and surface characteristics, which may be reasons for the different results among studies \[[@B17], [@B18]\]. We applied the BioFlux 2000 microfluidic system in order to replicate intraocular physiological conditions and hydrodynamics. Baillif\'s study showed that the stabilization phase was reached after 28 h of incubation \[[@B19]\]. In our study, we incubated the IOLs for 36 h to maximize the difference among groups.

Bacteria embedded in a biofilm are more able to resist attacks by antibiotics or host defences, and biofilm bacteria can survive the use of antiseptics and/or antibiotics at extremely high concentrations, which may lead to persisting infections \[[@B20], [@B21]\]. At that point, removing the infected device should be considered to end the infection. In our study, there was membrane formation in all patients during the routine anti-infection medication treatment, and it took quite a long time for the anti-infection treatment afterward to be effective.

In our study, bacterial adhesion and colonization were strongest both on the heparin surface-modified (HSM) hydrophilic acrylic IOL and the IOL used in our ten patients and weakest on the hydrophobic acrylic polymer. This may be related to the surface modification and IOL material. The heparin could inhibit inflammation for certain patients, but this modification may meanwhile increase the bacterial adherence. However, there were no cases of endophthalmitis among patients given HSM hydrophilic acrylics IOLs. This may be related to the rare application of this type of IOL in our clinical practice. Biofilm formation on polymer surfaces is a complex process that depends on the bacterial characteristics, the nature of the polymer material, and environmental factors. However, among all of the nonspecific interactions, hydrophilic/hydrophobic interactions had the greatest influence on the bacterial primary attachment \[[@B11]\]. Bacteria with hydrophilic properties generally prefer hydrophilic material surfaces \[[@B22]--[@B25]\]. Furthermore, different isolates of *S. epidermidis* may differ significantly with regard to their adherence to the same IOL \[[@B24], [@B25]\]. This may explain the discrepancy between our study and previous studies. Furthermore, a large number of crystals and a rougher surface than found on hydrophobic IOLs may contribute to more bacteria adhering to the surface of hydrophilic acrylic IOLs.

5. Conclusions {#sec5}
==============

It is obviously difficult to draw definitive conclusions from our case series, and further clinical experience and research are necessary to validate our results. However, we hereby present a case series of endophthalmitis to highlight the importance of biofilm production and discuss the treatments. The findings in the present study of bacterial biofilm formation on the surface of IOLs allow for further understanding of biomedical device-related infections such as endophthalmitis. Furthermore, designing a material that could reduce or inhibit bacterial adhesion and growth on its surfaces to decrease the incidence of endophthalmitis should be a future research concern.
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###### 

The demographics of the ten cases implanted with QUATRIX Aspheric IOLs.

  Case no.   Age   Gender   Medical history   Ophthalmic history    Preoperative VA   Onset (days)   VA on POE   Anterior chamber        Vitreous opacification   AC/vitreous tapping   Tropical treatment                                     Systemic treatment         Final VA   Final BCVA
  ---------- ----- -------- ----------------- --------------------- ----------------- -------------- ----------- ----------------------- ------------------------ --------------------- ------------------------------------------------------ -------------------------- ---------- ------------
  1          74    M        ---               AMD                   20/100            32             20/200      Tyn (+) Cell (+)        Mild                     No                    Levofloxacin and tobramycin eye drop                   Oral levofloxacin          20/50      20/25
  2          70    F        Hypertension      ---                   20/200            55             20/400      Tyn (++) Cell (++)      Mild to moderate         Yes, (-)              Intravitreal ceftazidime + norvancomycin               Intravenous levofloxacin   20/80      20/40
  3          64    M        ---               ---                   20/80             5              20/200      Tyn (+) Cell (+)        Mild                     No                    Gatifloxacin and tobramycin eye drop                   Intravenous levofloxacin   20/40      20/25
  4          74    F        ---               ---                   20/100            9              20/100      Tyn (+) Cell (+)        Mild                     No                    Gatifloxacin and tobramycin eye drop                   Oral levofloxacin          20/40      20/32
  5          76    F        Hypertension      ---                   20/200            26             20/200      Tyn (++) Cell (++)      Mild to moderate         Yes, (-)              Intravitreal ceftazidime + norvancomycin               Intravenous levofloxacin   20/80      20/50
  6          58    F        Diabetes          ---                   20/200            40             20/400      Tyn (+++) Cell (++++)   Mild to moderate         Yes, (-)              YAG + PPV + Intravitreal ceftazidime + norvancomycin   Oral levofloxacin          20/40      20/25
  7          67    F        ---               ---                   20/100            3              20/200      Tyn (+) Cell (+)        Mild to moderate         No                    Gatifloxacin and tobramycin eye drop                   Oral levofloxacin          20/50      20/32
  8          56    M        ---               Pathological myopia   20/400            65             20/2000     Tyn (+++) Cell (++)     Moderate                 Yes, *S. epi*         PPV + Intravitreal ceftazidime + norvancomycin         Oral levofloxacin          20/100     20/40
  9          74    F        ---               ---                   20/80             24             20/200      Tyn (+) Cell (+)        Mild to moderate         No                    Gatifloxacin eye drop + YAG                            Oral levofloxacin          20/20      20/25
  10         52    M        ---               Pathological myopia   20/50             16             20/400      Tyn (++) Cell (++)      Mild to moderate         Yes, (-)              Intravitreal ceftazidime + norvancomycin               Oral cefaclor              20/50      20/32

AMD = age-related macular degeneration; VA = visual acuity; BCVA = best-corrected visual acuity; PPV = pars plana vitrectomy; YAG = yttrium aluminium garnet.

###### 

Intraocular lens characteristics.

  Group   Material                                             Manufacturer                        Model number                 Style of haptics   Eyes implanted with the IOL (May 2015--May 2016)
  ------- ---------------------------------------------------- ----------------------------------- ---------------------------- ------------------ --------------------------------------------------
  A       Hydrophilic acrylic                                  Human Optics AG                     MCX11ASP                     1-piece            998
  B       Hydrophilic acrylic (heparin surface modification)   Hexa ision SARL                     HQ-201HEP                    1-piece            51
  C       Hydrophilic acrylic                                  Rayner Intraocular Lenses Limited   970C                         1-piece            2279
  D       Hydrophilic acrylic                                  Croma GmbH                          QUATRIX Aspheric             1-piece            461
  E       Hydrophilic acrylic                                  Croma GmbH                          QUATRIX Aspheric Evolutive   1-piece            NA
  F       Hydrophobic acrylic                                  Alcon Laboratories, Inc.            SN60WF                       1-piece            800
  G       Hydrophobic acrylic                                  Abbott Medical Optics, Inc.         TECNIS ZA9003                3-piece            153

###### 

Bacterial population enumeration in IOL biofilms (CFU/mm^2^).

  Group       A             B                C              D               E               F              G
  ----------- ------------- ---------------- -------------- --------------- --------------- -------------- --------------
              6886          132631           58670          118483          76041           35368          37490
              8710          107873           45632          86652           90189           47747          31124
              10524         99031            40743          93726           68968           33600          33423
  Mean ± SD   8706 ± 1819   113178 ± 17416   48348 ± 9267   99620 ± 16714   78399 ± 10805   38905 ± 7708   34012 ± 3223
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